Mark Eckersdorff
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Aging top 5%
Papers in ⓘ
- Aging 2
- Genetics, Aging, and Longevity in Model Organisms 2
-
- Sirtuins and Resveratrol in Medicine 2
- Co-authors
- David O. Ferguson (7 shared papers)Frederick W. Alt (6 shared papers)JoAnn Sekiguchi (3 shared papers)Craig H. Bassing (2 shared papers)Charles Lee (2 shared papers)John Manis (2 shared papers)David B. Lombard (3 shared papers)Heikyung Suh (1 shared paper)
- Journals
- Journal of Visualized Experiments (2 papers)Cell (2 papers)Genes & Development (1 paper)Endocrinology (1 paper)Human Molecular Genetics (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Mark Eckersdorff
13 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Geriatrics and Gerontology 143
- Aging 58
- Molecular Biology 1.3k
- Cancer Research 266
- Oncology 471
Countries citing papers authored by Mark Eckersdorff
This map shows the geographic impact of Mark Eckersdorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Eckersdorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Eckersdorff more than expected).
Fields of papers citing papers by Mark Eckersdorff
This network shows the impact of papers produced by Mark Eckersdorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Eckersdorff. The network helps show where Mark Eckersdorff may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Eckersdorff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 397 | |
| 2 | 2008 | 269 | |
| 3 | 2009 | 208 | |
| 4 | 2003 | 156 | |
| 5 | 2015 | 114 | |
| 6 | 2005 | 104 | |
| 7 | 2004 | 100 | |
| 8 | 2004 | 83 | |
| 9 | 2012 | 57 | |
| 10 | 2005 | 47 | |
| 11 | 2015 | 15 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 3 |
About Mark Eckersdorff
Mark Eckersdorff is a scholar working on Aging, Geriatrics and Gerontology, Oncology, Rehabilitation and Cancer Research, having authored 13 papers that have together received 1.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (6 papers), Cancer-related Molecular Pathways (5 papers), Sirtuins and Resveratrol in Medicine (2 papers), CAR-T cell therapy research (2 papers), CRISPR and Genetic Engineering (2 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Genetics, Aging, and Longevity in Model Organisms (2 papers). The work is most often cited by research in Geriatrics and Gerontology (143 citations), Aging (58 citations), Molecular Biology (1.3k citations), Cancer Research (266 citations) and Oncology (471 citations). Mark Eckersdorff has collaborated with scholars based in United States and Netherlands. Frequent co-authors include David O. Ferguson, Frederick W. Alt, JoAnn Sekiguchi, Craig H. Bassing, Charles Lee, John Manis, David B. Lombard, Heikyung Suh, R T Bronson and Megan Gleason. Their work appears in journals such as Journal of Visualized Experiments, Cell, Genes & Development, Endocrinology and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.